how is cryptocurrency worth anything, Block

The concept of Shanghai's state-owned enterprise reform was active at the beginning to create an international daily limit. The concept of Shanghai's state-owned enterprise reform was active at the beginning, creating an international and Fudan Fuhua daily limit, and Kaiye, First Medicine, Shibei High-tech and Xujiahui followed suit.The central bank conducted a 7-day reverse repurchase operation of 78.6 billion yuan today, and the winning bid rate was 1.50%, which was the same as before. As 41.3 billion yuan of 7-day reverse repurchase expired today, the net investment on that day was 37.3 billion yuan.South Korean prosecutors seized and searched the South Korean Special Forces Command. (CCTV News)

The decline of treasury bond futures expanded, with the 30-year main contract falling by 0.50%, the 30-year main contract falling by 0.50%, the 10-year main contract falling by 0.18%, the 5-year main contract falling by 0.12% and the 2-year main contract falling by 0.05%.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.Byte transmission improves the priority of clipping and dreaming business, and the official has not responded for the time being. Byte management judges that AI dialogue products (or chatbot products) may only be the "intermediate state" of AI products, and a more ideal product form for a long time requires a more visual user experience and a lower threshold for users to use. Therefore, Byte has promoted the product priority of Dreaming, and tried to create a "Tik Tok" in the AI ​ ​ era with a new path. The media asked Byte for verification on this news, and the official has not responded yet. (Sina Technology)

Treasury futures collectively opened lower, with 30-year main contracts down 0.38%, 30-year main contracts down 0.38%, 10-year main contracts down 0.11%, 5-year main contracts down 0.06% and 2-year main contracts down 0.04%.The AI company under Jiangshan Holdings suddenly announced its dissolution: the funds were unsustainable and all employees were dismissed. Eagle Eye Wisdom Chinese Medicine, an AI medical company under Jiangshan Holdings, a Hong Kong-listed company, suddenly announced its dissolution and all employees were dismissed. A number of employees of Hawkeye Wisdom Chinese Medicine said that at 23:31 in the middle of December 9, Lv Jiyou, general manager of the company's strategic management department and director of the president's office, suddenly issued a notice of dissolution in the enterprise WeChat staff. According to the notice, due to huge problems in the company's operation and unsustainable funds, the company was dissolved on December 9, 2024 and all employees were dismissed after research by shareholders. The salary of all employees will be calculated on December 9, 2024, and the social security accumulation fund will be paid in November. The social security, medical insurance, individual tax and accumulation fund of the previous month will be paid later, and the unpaid wages will be paid in batches according to the resignation situation. (Sina Technology)Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.